Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,844,332 8.700% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,869,392 8.800% |
3,869,392 (New Position) |
Filing History |
| 2023-02-14 3:52 pm Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Avidity Partners Management LP | 1,855,400 4.200% |
-1,894,600 (-50.52%) |
Filing History |
| 2023-02-14 2:50 pm Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 0 0.000% |
-3,318,647 (Position Closed) |
Filing History |
| 2023-02-14 10:04 am Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 0 0.000% |
-2,637,192 (Position Closed) |
Filing History |
| 2023-02-09 10:37 am Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-3,404,707 (Position Closed) |
Filing History |
| 2022-11-10 4:02 pm Purchase |
2022-10-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,844,332 8.700% |
3,844,332 (New Position) |
Filing History |
| 2022-10-27 09:56 am Purchase |
2022-10-26 | 13G | ESSA Pharma Inc. EPIX |
Avidity Partners Management LP | 3,750,000 8.500% |
3,750,000 (New Position) |
Filing History |
| 2022-07-12 4:40 pm Purchase |
2022-07-08 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.900% |
4,183,387 (+91.64%) |
Filing History |
| 2022-02-14 1:43 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 4,565,242 9.990% |
859,953 (+23.21%) |
Filing History |
| 2022-02-14 11:46 am Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 3,318,647 7.500% |
983,479 (+42.12%) |
Filing History |
| 2022-02-14 08:46 am Sale |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 2,637,192 6.000% |
-391,527 (-12.93%) |
Filing History |
| 2022-02-11 5:23 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Vivo Capital IX, LLC | 624,902 1.400% |
624,902 (New Position) |
Filing History |
| 2022-02-11 5:10 pm Unchanged |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFIZER INC PFE |
1,675,000 3.810% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:46 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 5,015,814 11.400% |
250,000 (+5.25%) |
Filing History |
| 2022-02-11 1:43 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
JANUS HENDERSON GROUP PLC JHG |
3,404,707 7.700% |
3,404,707 (New Position) |
Filing History |
| 2022-02-10 5:27 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,525,457 8.010% |
50,799 (+1.46%) |
Filing History |
| 2022-01-12 4:30 pm Sale |
2022-01-10 | 13D | ESSA Pharma Inc. EPIX |
Clarus Lifesciences III L.P. | 2,187,912 4.960% |
-1,291,202 (-37.11%) |
Filing History |
| 2021-08-23 4:55 pm Sale |
2021-08-16 | 13G | ESSA Pharma Inc. EPIX |
DRIEHAUS CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,048,524 (Position Closed) |
Filing History |
| 2021-08-17 1:57 pm Purchase |
2021-08-16 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 4,765,814 10.800% |
2,780,000 (+139.99%) |
Filing History |